In summary, we propose that hepatic RIG-I is constitutively mono-methylated at K18 and K146, and increased methylated RIG-I during steatosis promotes cholesterol synthesis by inhibiting HMGCR phosphorylation, thus promoting NAFLD progression. The gene discussed is HMGCR; the disease is metabolic dysfunction-associated steatotic liver disease.